• Medientyp: E-Artikel
  • Titel: Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING
  • Beteiligte: Pinjusic, Katarina; Ambrosini, Giovanna; Lourenco, Joao; Fournier, Nadine; Iseli, Christian; Guex, Nicolas; Egorova, Olga; Nassiri, Sina; Constam, Daniel B.
  • Erschienen: Frontiers Media SA, 2024
  • Erschienen in: Frontiers in Immunology
  • Sprache: Nicht zu entscheiden
  • DOI: 10.3389/fimmu.2023.1335207
  • ISSN: 1664-3224
  • Schlagwörter: Immunology ; Immunology and Allergy
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>The transforming growth factor-β (TGF-β) family member activin A (hereafter Activin-A) is overexpressed in many cancer types, often correlating with cancer-associated cachexia and poor prognosis. Activin-A secretion by melanoma cells indirectly impedes CD8<jats:sup>+</jats:sup> T cell-mediated anti-tumor immunity and promotes resistance to immunotherapies, even though Activin-A can be proinflammatory in other contexts. To identify underlying mechanisms, we here analyzed the effect of Activin-A on syngeneic grafts of <jats:italic>Braf</jats:italic> mutant YUMM3.3 mouse melanoma cells and on their microenvironment using single-cell RNA sequencing. We found that the Activin-A-induced immune evasion was accompanied by a proinflammatory interferon signature across multiple cell types, and that the associated increase in tumor growth depended at least in part on pernicious STING activity within the melanoma cells. Besides corroborating a role for proinflammatory signals in facilitating immune evasion, our results suggest that STING holds considerable potential as a therapeutic target to mitigate tumor-promoting Activin-A signaling at least in melanoma.</jats:p>
  • Zugangsstatus: Freier Zugang